Details of the Drug
General Information of Drug (ID: DM7UVOD)
Drug Name |
DH97
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
DH 97; DH97; 343263-95-6; N-[2-(2-benzyl-1H-indol-3-yl)ethyl]pentanamide; N-(2-(2-Benzyl-1H-indol-3-yl)ethyl)pentanamide; Luzindole,N-pentanoyl; Tocris-1218; AC1MRF3Z; 220339-00-4; N-pentanoyl 2-benzyltryptamine; N-Pentanoyl-2-benzyltryptamine; SCHEMBL1626901; GTPL3366; CHEMBL1327247; CHEBI:92107; CTK8E7620; BDBM85384; DTXSID90392749; MolPort-003-983-554; HMS3267D11; ZINC2581407; BN0182; AKOS024456472; NCGC00025049-01; NCGC00025049-02; ACM343263956; RT-012298; FT-0763744; SR-01000597373; SR-01000597373-1; J-019556
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 334.5 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 8 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References